These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30148799)

  • 21. Anti-CENPI autoantibodies in scleroderma patients with features of autoimmune liver diseases.
    Hamdouch K; Rodríguez C; Pérez-Venegas J; Rodríguez I; Astola A; Ortiz M; Yen TJ; Bennani M; Valdivia MM
    Clin Chim Acta; 2011 Nov; 412(23-24):2267-71. PubMed ID: 21888900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies in scleroderma and polymyositis: an update.
    McCarty GA
    Semin Dermatol; 1991 Sep; 10(3):206-16. PubMed ID: 1931570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological characterization of heterochromatin protein p25beta autoantibodies and relationship with centromere autoantibodies and pulmonary fibrosis in systemic scleroderma.
    Furuta K; Hildebrandt B; Matsuoka S; Kiyosawa K; Reimer G; Luderschmidt C; Chan EK; Tan EM
    J Mol Med (Berl); 1998 Jan; 76(1):54-60. PubMed ID: 9462868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis.
    Cabral-Marques O; Riemekasten G
    Autoimmun Rev; 2016 Jul; 15(7):690-4. PubMed ID: 26970493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Fc gamma receptor-specific autoantibodies in localized and systemic scleroderma.
    Davis K; Boros P; Keltz M; Unkeless JC; Fleischmajer R
    J Am Acad Dermatol; 1995 Oct; 33(4):612-6. PubMed ID: 7673494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex.
    Yang JM; Hildebrandt B; Luderschmidt C; Pollard KM
    Arthritis Rheum; 2003 Jan; 48(1):210-7. PubMed ID: 12528121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibody associations with MHC class II antigens in scleroderma and autoimmune vasculitis.
    Thomson JB; Hulse D; Galbraith I; McKay IC; Field M
    Autoimmunity; 1994; 19(4):265-9. PubMed ID: 7578853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Scleroderma associated autoantibodies - clinical and diagnostic relevance].
    Mierau R; Genth E
    Z Rheumatol; 2006 Jul; 65(4):279-84. PubMed ID: 16788839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional autoantibodies in systemic sclerosis.
    Günther J; Rademacher J; van Laar JM; Siegert E; Riemekasten G
    Semin Immunopathol; 2015 Sep; 37(5):529-42. PubMed ID: 26292621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-annexin V antibodies and digital ischemia in patients with scleroderma.
    Sugiura K; Muro Y
    J Rheumatol; 1999 Oct; 26(10):2168-72. PubMed ID: 10529134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis.
    Pauling JD; Salazar G; Lu H; Betteridge ZE; Assassi S; Mayes MD; McHugh NJ
    Rheumatology (Oxford); 2018 Apr; 57(4):712-717. PubMed ID: 29294089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies in scleroderma.
    Pollard KM; Reimer G; Tan EM
    Clin Exp Rheumatol; 1989; 7 Suppl 3():S57-62. PubMed ID: 2691161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-Scl-70 and anti-centromere autoantibodies. Biological markers of 2 forms of systemic scleroderma].
    Johanet C; Agostini MM; Vayssairat M; Abuaf N
    Presse Med; 1989 Feb; 18(5):207-11. PubMed ID: 2522207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autoantibodies in systemic sclerosis (scleroderma)].
    Greenbaum E; Laufer M; Shoenfeld J
    Harefuah; 1993 Mar; 124(6):370-4. PubMed ID: 8388360
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunologic aspects of scleroderma.
    White B
    Curr Opin Rheumatol; 1995 Nov; 7(6):541-5. PubMed ID: 8579976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies in scleroderma and their association with the clinical profile of the disease. A study of 66 patients from southern Brazil.
    Skare TL; Fonseca AE; Luciano AC; Azevedo PM
    An Bras Dermatol; 2011; 86(6):1075-81. PubMed ID: 22281893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Novel autoantibodies in inflammatory myopathies and systemic sclerosis].
    Ribi C
    Rev Med Suisse; 2015 Jan; 11(456-457):25-9. PubMed ID: 25799647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension.
    Ulanet DB; Wigley FM; Gelber AC; Rosen A
    Arthritis Rheum; 2003 Feb; 49(1):85-92. PubMed ID: 12579598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening.
    Shah AA; Casciola-Rosen L
    Curr Opin Rheumatol; 2015 Nov; 27(6):563-70. PubMed ID: 26352736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.